| Literature DB >> 34606785 |
Guinther G Badessa1, Juliano Pinheiro Almeida2, Julia Tizue Fukushima2, Marianne Badessa3, Felipe Colella2, Marcelo L Torres2, Milton Ruiz Alves3, Luiz Fernando R Falcão2, Cirilo Haddad Silveira2, Adeli Mariane Vieira Lino Alfano2, Mauricio Amaral Neto2, Aloísio Fumio Nakashima4, Maria José C Carmona2.
Abstract
BACKGROUND: Elderly patients may present with visual function impairment after surgery, which may increase the incidence of postoperative delirium and falls and decrease their quality of life. The aim of this study was to assess visual function in elderly patients after long-duration nonocular surgery to determine the incidence and risk factors for visual function impairment after surgery.Entities:
Keywords: Aged; Postoperative complications; Visual disorders
Mesh:
Year: 2021 PMID: 34606785 PMCID: PMC9373636 DOI: 10.1016/j.bjane.2021.09.002
Source DB: PubMed Journal: Braz J Anesthesiol ISSN: 0104-0014
Figure 1Study protocol fluxogram.
Figure 2Study flow chart.
Baseline characteristics of the study participants.
| Variable | Visual function alterations | ||
|---|---|---|---|
| No (n = 86) | Yes (n = 21) | ||
| Age (years) | 66 (62–72) | 68 (63–74) | 0.494 |
| BMI (kg.m-2) | 25 (23–27) | 22 (21–26) | 0.015 |
| Physical status | |||
| ASA I | 8 (9.3%) | 2 (9.5%) | 1.000 |
| ASA II | 78 (90.7%) | 19 (90.5%) | |
| Comorbidities | |||
| Systemic arterial hypertension | 75 (87.3%) | 17 (80.9%) | 0.488 |
| Atrial fibrillation | 7 (87.5%) | 1 (12.5%) | 1.000 |
| COPD | 5 (5.8%) | 2 (9.5%) | 0.621 |
| Smoking | 9 (10.5%) | 8 (38.1%) | 0.005 |
| Hypothyroidism | 1 (1.2%) | 0 (0%) | 1.000 |
| Diabetes mellitus | 12 (13.9%) | 9 (42.9%) | 0.006 |
| Dyslipidaemia | 7 (8.1%) | 3 (14.3%) | 0.408 |
| GERD | 0 (0%) | 2 (9.5%) | 0.037 |
| Hepatitis B | 0 (0%) | 2 (9.5%) | 0.037 |
| CRF | 2 (2.3%) | 0 (0%) | 1.000 |
| Procedures | 0,012 | ||
| Gastrointestinal procedure | 20 (23.3%) | 11 (52.4%) | |
| Gynecologic procedure | 11 (12.8%) | 1 (4.8%) | |
| Liver and biliary tract procedure | 13 (15.1%) | 3 (14.3%) | |
| Peripheral vascular surgery | 11 (12.8%) | 5 (23.8%) | |
| Plastic surgery | 1 (1.2%) | 0 (0%) | |
| Urologic procedure | 30 (34.9%) | 1 (4.8%) | |
Data are presented as absolute (n) and relative (%) values or medians and interquartile ranges. BMI, Body Mass Index; COPD, Chronic Obstructive Pulmonary Disease; GERD, Gastroesophageal Reflux Disease; CRF, Chronic Renal Failure.
cChi-Square test.
Mann-Whitney U test.
Fisher’s exact test.
Likelihood Ratio.
Postoperative clinical and laboratory data of the study participants.
| Variable | Visual function alterations | ||
|---|---|---|---|
| No (n = 86) | Yes (n = 21) | ||
| Duration of anesthesia (min) | 160 (140–240) | 260 (170–340) | 0.005 |
| Duration of surgery (min) | 140 (125–200) | 220 (148–310) | 0.007 |
| Fluid therapy and blood transfusion | |||
| Crystalloids (mL) | 1500 (1500–3000) | 3000 (1550–3500) | 0.001 |
| Red blood cell transfusion | 0 (0%) | 2 (9.5%) | 0.037 |
| Preoperative Hb (g.dL-1) | 13 (12–13) | 13 (11–13) | 0.818 |
| Postoperative Hb (g.dL-1) | 12 (11–13) | 10 (10–12) | 0.001 |
| Surgical position | |||
| Head-up | 6 (6.9%) | 6 (28.6%) | 0.004 |
| Trendelenburg | 54 (62.8%) | 14 (66.7%) | 0.137 |
| Anesthetic agents | |||
| Remifentanil | 12 (13.9%) | 3 (14.3%) | 1.000 |
| Succinylcholine | 1 (1.2%) | 1 (4.8%) | 0.355 |
| Etomidate | 1 (1.2%) | 0 (0%) | 1.000 |
| Fentanyl (mcg) | 250 (250–300) | 350 (275–500) | 0.002 |
| Propofol (mg) | 150 (140–166) | 160 (140–170) | 0.660 |
| Cisatracurium (mg) | 16 (0–20) | 12 (0–20) | 0.531 |
| Midazolam (mg) | 2 (0–5) | 0 (0–4) | 0.418 |
| Rocuronium (mg) | 50 (50–50) | 50 (0–50) | 0.515 |
| Vasopressor agents (ephedrine and metaraminol) | 16 (18.6%) | 12 (57.1%) | <0.001 |
| Vasopressor agents (ephedrine and metaraminol) | 0 (0–0) | 5 (0–5) | 0.001 |
Data are presented as absolute (n) and relative (%) values or as medians and interquartile ranges. Hb, Hemoglobin.
Mann-Whitney U test.
Fisher’s exact test.
Chi-Square test.
Patient results from preoperative and postoperative day 3 visual acuity tests and intraocular pressure measurements.
| Variable | Total (n = 107) | No visual alteration (n = 86) | Visual alteration (n = 21) | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Mean | SD | Mean | SD | Mean | SD | |||||
| LogMAR Snellen – right eye | ||||||||||
| Preoperative | 0.28 | 0.19 | 0.29 | 0.20 | 0.23 | 0.14 | 0.189 | |||
| POD 3 | 0.31 | 0.21 | 0.001 | 0.29 | 0.21 | 0.233 | 0.39 | 0.19 | <0.001 | 0.035 |
| LogMAR Snellen – left eye | ||||||||||
| Preoperative | 0.28 | 0.20 | 0.29 | 0.20 | 0.23 | 0.15 | 0.237 | |||
| POD 3 | 0.31 | 0.21 | 0.001 | 0.29 | 0.21 | 0.235 | 0.40 | 0.21 | <0.001 | 0.022 |
| IOP – right eye | ||||||||||
| Preoperative | 14.55 | 1.75 | 14.59 | 1.74 | 14.38 | 1.80 | 0.621 | |||
| POD 3 | 14.77 | 1.79 | 0.001 | 14.56 | 1.75 | 0.320 | 15.62 | 1.77 | <0.001 | 0.014 |
| IOP – left eye | ||||||||||
| Preoperative | 14.58 | 1.81 | 14.63 | 1.82 | 14.38 | 1.80 | 0.578 | |||
| POD 3 | 14.79 | 1.88 | 0.001 | 14.59 | 1.82 | 0.320 | 15.57 | 1.96 | <0.001 | 0.032 |
| Refraction test – right eye | ||||||||||
| Preoperative | 1.67 | 0.59 | 1.73 | 0.63 | 1.43 | 0.35 | 0.004 | |||
| POD 3 | 1.72 | 0.58 | <0.001 | 1.73 | 0.63 | – | 1.68 | 0.32 | <0.001 | 0.600 |
| Refraction test – left eye | ||||||||||
| Preoperative | 1.62 | 0.59 | 1.68 | 0.59 | 1.37 | 0.52 | 0.031 | |||
| POD 3 | 1.67 | 0.57 | <0.001 | 1.69 | 0.58 | 0.159 | 1.61 | 0.52 | <0.001 | 0.556 |
SD, Standard Deviation; POD 3, Postoperative Day 3; IOP, Intraocular Pressure.
Student’s t test.
Repeated-measures analysis of variance (ANOVA): preoperative vs. postoperative.
Repeated-measures ANOVA: no visual alteration vs. visual alteration.
Perioperative monitoring data of the study participants.
| Monitoring variable | Visual function alterations | ||
|---|---|---|---|
| No (n = 86) | Yes (n = 21) | ||
| Temperature (°C) | |||
| Before induction | 36 (36–36) | 36 (35–36) | 0.062 |
| After induction | 35 (35–36) | 35 (35–36) | 0.751 |
| At the end of surgery | 35 (35–36) | 35 (35–36) | 0.984 |
| SpO2 (%) | |||
| Before induction | 99 (98–99) | 97 (96–99) | <0.001 |
| After induction | 99 (99–99) | 99 (98–99) | 0.003 |
| At the end of surgery | 99 (99–99) | 97 (96–99) | <0.001 |
| ETCO2 (mmHg) | |||
| Before induction | 42 (39–42) | 42 (39–44) | 0.344 |
| After induction | 35 (35–35) | 35 (31–36) | 0.207 |
| At the end of surgery | 39 (38–40) | 39 (37–42) | 0.864 |
| HR (bpm) | |||
| Before induction | 73 (64–80) | 70 (66–81) | 0.832 |
| After induction | 65 (59–72) | 72 (61–80) | 0.041 |
| At the end of surgery | 66 (60–73) | 72 (70–85) | 0.001 |
| SBP (mmHg) | |||
| Before induction | 130 (124–136) | 140 (130–140) | 0.008 |
| After induction | 100 (100–112) | 90 (85–110) | 0.002 |
| At the end of surgery | 125 (120–130) | 124 (115–130) | 0.568 |
| DBP (mmHg) | |||
| Before induction | 80 (67–85) | 80 (65–85) | 0.686 |
| After induction | 55 (45–60) | 50 (45–60) | 0.207 |
| At the end of surgery | 65 (60–74) | 70 (60–83) | 0.320 |
| Diuresis (mL) | 400 (328–500) | 500 (300–650) | 0.225 |
Data are presented as the median and interquartile range. SpO2, Peripheral Oxygen Saturation; ETCO2, End-Tidal Carbon Dioxide; HR, Heart Rate; SBP, Systolic Blood Pressure; DBP, Diastolic Blood Pressure.
Multivariable analysis of predictive factors for postoperative visual function alteration.
| Variable | OR | 95% CI | ||
|---|---|---|---|---|
| BMI (kg.m-2) | 0.627 | 0.459 | 0.858 | 0.030 |
| SpO2 at the end of surgery (%) | 0.142 | 0.053 | 0.382 | <0.001 |
| HR after induction (bpm) | 1.175 | 1.057 | 1.306 | 0.003 |
| SBP after induction (mmHg) | 0.848 | 0.767 | 0.938 | 0.001 |
| Duration of surgery (min) | 1.025 | 1.010 | 1.041 | 0.001 |
OR, Odds Ratio; CI, Confidence Interval; SpO2, Peripheral Oxygen Saturation; HR, Heart Rate; SBP, Systolic Blood Pressure.